Dr. Soriano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
836 Sunset Lake Blvd
Suite 101
Venice, FL 34292Phone+1 941-408-0500Fax+1 941-496-8558
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2004 - 2007
- Forest Park HospitalResidency, Internal Medicine, 2003 - 2004
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2001 - 2003
- Universidad de Guayaquil, School of Medicine.Class of 1998
Certifications & Licensure
- FL State Medical License 2013 - 2026
- TX State Medical License 2005 - 2024
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2014
Clinical Trials
Publications & Presentations
PubMed
- 32 citationsPhase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC.Roy S. Herbst, Hendrik Tobias Arkenau, Johanna C. Bendell, Edward Arrowsmith, Martin Wermke
Journal of Thoracic Oncology. 2021-02-01 - 20 citationsRamucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.Ian Chau, Nicolas Penel, Andres O. Soriano, Hendrik-Tobias Arkenau, Jennifer L. Cultrera
Cancers. 2020-10-15 - 184 citationsRamucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a m...Roy S. Herbst, Hendrik-Tobias Arkenau, Rafael Santana-Davila, Emiliano Calvo, Luis Paz-Ares
The Lancet. Oncology. 2019-08-01
Press Mentions
- Florida Cancer Specialists & Research Institute Appoints New Members to Executive BoardJanuary 4th, 2023
Other Languages
- Spanish, French, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: